Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
79.55
+1.08 (1.38%)
Aug 21, 2026, 10:46 AM EDT - Market open
KNSA Market Cap
KNSA has a market cap or net worth of $6.21 billion as of August 21, 2026. Its market cap has increased by 152.20% in one year.
Market Cap
6.21B
Enterprise Value
5.69B
1-Year Change
152.20%
Ranking
Category
Stock Price
$79.55
ChartMarket Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $914.40M to $6.21B, an increase of 578.79%. That is a compound annual growth rate of 26.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 6.21B | 98.52% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
| May 24, 2018 | 914.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elanco Animal Health | 12.24B |
| Dr. Reddy's Laboratories | 10.21B |
| Alkermes | 8.42B |
| Hims & Hers Health | 7.25B |
| Liquidia | 6.74B |
| Lantheus Holdings | 6.56B |
| Amneal Pharmaceuticals | 5.78B |
| Indivior Pharmaceuticals | 4.61B |